How MSI and TMB Factor into Current Biomarker Testing Panels

Sanjiv S. Agarwala, MD

Video Categories: 2018 ASCO Insights, Biomarkers, and Video Library

Dr Sanjiv Agarwala discusses the usefulness of MSI and TMB as novel biomarkers for various cancer types. His argument is that the first FDA approval of a therapy based on MSI rather than tumor type makes this biomarker useful, but TMB is not yet ready for “prime time.”

July 25, 2018

How Oncologists and Pathologists Can Best Collaborate to Provide Precision Medicine for Their Patients

Dr David Spigel discusses how medical oncologists and the rest of the cancer care team can best communicate with pathologists to help make informed treatment decisions for individual patients and set up new assays for emerging biomarkers as they are discovered.

July 29, 2015

Navigating the High Cost of Cancer Treatments

Dr. Jorge Cortes addresses the difficulties patients have in dealing with the high cost of cancer treatments and calls for an effort to make these drugs more affordable. He asserts that physicians should try to help by understanding the needs of their patients, educating them, and involving their social workers [ Read More ]